Overview

Counseling Conditions for Buprenorphine in a Primary Care Clinic - 1

Status:
Completed
Trial end date:
2004-02-01
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this study is to compare the Standard Medical Management (SMM) vs. SMM enhanced with additional education about addiction and recovery (Enhanced Medical Management, EMM)
Phase:
Phase 2
Accepts Healthy Volunteers?
Accepts Healthy Volunteers
Details
Lead Sponsor:
National Institute on Drug Abuse (NIDA)
Yale University
Collaborators:
National Institute on Drug Abuse (NIDA)
Yale University
Treatments:
Buprenorphine
Criteria
Inclusion criteria: Subjects meeting FDA criteria for opioid agonist maintenance treatment
and DSM-IV criteria for opioid dependence will be eligible for the study. Women of
childbearing age will be included provided they agree to adequate contraception and to
monthly pregnancy monitoring throughout the study.

Exclusion criteria include: pregnancy, current dependence on alcohol, benzodiazepines or
sedatives; current suicide or homicide risk; current psychotic disorder or major
depression; inability to read or understand English; life-threatening or unstable medical
problems.